|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encntr screen for malignant neoplasm of genitourinary organs
ICD-10 (CM) Code and Descriptor
|
Z12.73 |
Encounter for screening for malignant neoplasm of ovary
Diagnosis Valid for Female Patient Only
This code is considered unacceptable as a principal diagnosis.
|
Z1273 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.96%
|
20.26%
|
10.09%
|
7.72%
|
5.76%
|
5.35%
|
3.46%
|
3.05%
|
1.69%
|
1.29%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.73*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
76830
|
TRANSVAGINAL US NON-OB |
209
|
209
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
199
|
199
|
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
199
|
199
|
|
76856
|
US EXAM PELVIC COMPLETE |
164
|
164
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
59
|
60
|
|
80053
|
COMPREHEN METABOLIC PANEL |
53
|
53
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
48
|
48
|
|
80061
|
LIPID PANEL |
41
|
41
|
|
84443
|
ASSAY THYROID STIM HORMONE |
37
|
37
|
|
82306
|
VITAMIN D 25 HYDROXY |
25
|
25
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
20
|
20
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
20
|
20
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
16
|
16
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
15
|
1,077
|
|
84439
|
ASSAY OF FREE THYROXINE |
13
|
13
|
|
86140
|
C-REACTIVE PROTEIN |
12
|
12
|
|
85027
|
COMPLETE CBC AUTOMATED |
12
|
12
|
|
80048
|
METABOLIC PANEL TOTAL CA |
11
|
11
|
|
82550
|
ASSAY OF CK (CPK) |
10
|
10
|
|
83550
|
IRON BINDING TEST |
10
|
10
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.73 related to the following DRG Codes:
951
|
